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Abstract
ICH Q10 was published in 2008, and presented a model for an effective Pharmaceutical Quality System (PQS).
However, the industry still has some way to go in embracing and implementing its principles in order to
achieve greater product realisation, to establish and maintain a state of control, and to facilitate continual
improvement.
ICH Q10 introduced us to two key enablers: Knowledge Management (KM) and Quality Risk Management
(QRM).[1] While the pharmaceutical industry has made progress in implementing the principles of QRM since
2008, there has been significantly slower progress in implementing knowledge management practices.
However, there may be solutions available to us today that may very well help speed up this implementation.
This journal article looks at how emerging technologies may assist pharmaceutical companies to capture,
share and transfer tacit knowledge.
The article focuses on the potential that emerging technology has to harness knowledge that is often difficult
to capture, namely tacit knowledge. Paper 1 in this series defines Tacit Knowledge and gives examples. Tacit
knowledge is typically acquired through experience, and it is intuitively understood. As this type of
knowledge and skill is challenging to articulate in pharmaceutical policies and procedures, it can be difficult
to transfer this information to other individuals. However, recent advances in technology may well hold the
key to unlocking this illusive and invaluable source of knowledge within our industry. This article explores
the benefits of using mixed reality technology (AR/VR) to assist pharmaceutical companies capture, share
and transfer knowledge with a focus on KM as applied to technology transfer.

Introduction
ICH Q10 defines Knowledge Management as:
‘a systematic approach to acquire, analyse, store and disseminate information’1]
Recent research into knowledge management has recognised that knowledge transfer is very important to
enable technology transfer.[2]
In the 14 years since ICH Q10 was released the emergence of new technologies that are reshaping the
competitive landscape across the pharmaceutical industry has occurred. The industrial internet of things
(IIoT), Industry 5.0 and digitalisation are all transforming the way pharmaceutical businesses and facilities
operate. This rapid advancement of digital technologies in the world today is arguably the most rapid
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advancement of any innovation in our history. One has to ponder: why isn’t Pharma taking advantage of this
technological revolution and using it for the betterment of KM?

Tacit Knowledge
Tacit knowledge is defined in the introductory paper of this journal issue, and is knowledge gained through
experience, However, one must question: do we actually understand what tacit knowledge is? Do we
understand the power and value of tacit knowledge?
Tacit knowledge can be defined as skills, ideas and experiences that people have but are not codified and
may not necessarily be easily expressed [3]. Individuals do not all learn in the same way so tacit knowledge
can be considered innately human. Although tacit knowledge is difﬁcult to articulate, its importance cannot
be overlooked, and techniques should be employed to surface and transfer appropriate tacit knowledge. [2]
In 2021 the International Society of Pharmaceutical Engineers (ISPE) released a Good Practice Guide on
Knowledge Management in the Pharmaceutical Industry. The guide proposes that a systematic knowledge
management program that manages tacit knowledge is a powerful tool to help maximise knowledge
awareness and to minimise knowledge loss that can threaten business continuity.[3] This article explores
ways emerging technology could be used as one solution to capture and manage tacit knowledge.

Emerging Technology – Introducing Mixed Reality Technology
Emerging technologies are quickly playing a greater role in how the Pharmaceutical and Life Sciences
Industry collects, stores and interprets its data and knowledge. Mixed reality technologies and platforms are
becoming more widespread in the application of displaying and interrogating this data and knowledge.
The Microsoft HoloLens2, is one of these mixed reality technology solutions, and is a digital headset that
uses augmented reality and holographic imagery that offers a unique user experience. Referred to as mixed
reality, this technology offers a blend of physical and digital worlds, unlocking natural and intuitive 3D
human, computer, and environmental interactions.[4] Figure 1, prepared by Microsoft illustrates how this
interaction works.

Figure 1: The interactions between computers, humans, and environments
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A recent research study by one of the authors of this paper carried out technical and industry based trials
supported by KENX USA, TU Dublin and BioPharmaChem Ireland (BPCI) using a Microsoft HoloLens2 mixed
reality headset. The study looked at three areas of interest within the Pharma industry; namely:
• Remote Equipment Qualifications
• Remote Audits & Inspections
• Remote Factory Acceptance Testing (FAT)
The results highlighted the potential that emerging technologies such as mixed reality technology have in
helping the pharmaceutical industry capture, share and transfer data and knowledge.[5] With this technology
personnel can ‘learn by doing’ using the augmented reality and holographic images, the research study
demonstrated how this type of technology could be used to integrate tacit knowledge into ‘On the Job
Training (OJTs)’ as well as troubleshooting across pharmaceutical facilities.
Not only can the use of emerging technologies by validation and technology transfer teams facilitate the
improvement of tacit knowledge capture and sharing (linked to speed to competency), it is also proven to
achieve significant cost savings (communication, travel, time). Therefore, the implementation of
technological solutions like mixed reality can be invaluable to the industry.
Mixed reality headsets help make knowledge transfer more effective. The multimedia/holographic imagery
enables the user to understand immediately what the end result should look like and therefore decrease
variability, confusion and risk. This is a great example of what the pharmaceutical industry is seeking to
achieve when it comes to knowledge management during technology transfer.
Figure 2 below illustrates a Microsoft HoloLens2 in use within Pharmaceutical plant by the author.

Figure 2: Microsoft HoloLens2 in use within a pharmaceutical plant.

Image Source: Microsoft Corporation & D.Nagle, Author

Competence learning using Mixed Reality Technology
As with the use of all technical solutions, competence in using Mixed Reality Technology is paramount. The
‘Conscious Competence Learning Model’ to support this was first described by management trainer Martin
Broadwell in 1969.[7] This model describes 4 stages of competence developed over time, in relation to
performance, namely:
1.
2.
3.
4.

Unconscious incompetence: The lack of awareness stage
Conscious incompetence: Awareness stage
Conscious competence: Step-by-step stage
Unconscious competence: Skilled stage

This model is illustrated in Figure 3
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Figure 3. ‘Conscious Competence Learning Model’

Knowledge that is captured or lost in Technology Transfer is fundamental to validation and commercial
manufacturing. Lost information results in missed opportunities and high risk. The authors explore the
Conscious Competence model and relate it to how emerging technology could be used to capture tacit
knowledge. This is important to understand as the use of tacit knowledge can accelerate a trainee through
the stages of competence:
➢ At the beginning of a Technology Transfer of a new product from A – B, technicians may be described
as having Conscious Incompetence
➢ Subject matter experts then train the receiving site technicians which results in them entering the
Conscious Competence state. This happens through on-the-job training and troubleshooting.
➢ Then, when technicians reach the Unconscious Competence they can ‘hit-the-ground running’. These
are the technicians that are desirable on teams at Technology Transfer. They have reached the tacit
knowledge stage, however, often this group of people generally don’t know that they are the ones
with the Tacit knowledge, the much sought-after knowledge!
➢ Unconscious Competence has its risks. It’s like knowing the ‘tricks-of-the-trade’ or ‘rules-of-thumbs’
that are not written down: the intricacies’ of doing a job. However, the fact that these steps are rarely
known or recorded, may lead to higher risk to processes through variability in results, observations
or defects.
It is the authors’ belief that using emerging technologies such as mixed reality headsets (e.g. Microsoft
HoloLens2) can help pharmaceutical companies deliver effective training programmes that will allow the
users to understand the intricacies of the job they are training for and/or the function they need to prepare
for. Using mixed reality headsets with the ‘Unconscious Competence’ subject matter expert should reduce
the reliance on tacit knowledge while also capturing this tacit knowledge in recorded training
sequence/video. This is invaluable information and can be saved and reused multiple times.
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The standard operating procedures (SOPs) used in the pharmaceutical industry still have variability due to
the interpretation of text and how limiting text is for “painting-pictures”. There is a need to reduce this
variability. Emerging technology could help reduce this variability and create more effective
learning/communication experience.
Research has shown that an unintentionally perpetuated fallacy within the industry which managers and
quality leaders often state unequivocally is that personnel must “always have the document in front of
them”. While this is certainly a well-intended statement, it belies the misguided belief that having documents
in front of workers helps to ensure a consistent and error-free process. Unfortunately, that belief is based
on an overly simplistic model of how work is performed, and it does not drive improved outcomes.” [10]

Conclusion
Tacit knowledge is powerful, but the pharmaceutical industry must identify the key people who have this
valuable knowledge, and mechanisms to capture and share this knowledge. A Pharmaceutical Regulatory
Science Team (PRST) research study in TU Dublin has shown that video media such as that used in mixed
reality headsets allows a trainee to understand WHAT is happening and WHY it’s happening.
The authors suggest that the next evolution of Technology Transfer and Validation in the Pharmaceutical
industry needs to include emerging technologies and the understanding of the power, requirement and
value of our people’s tacit knowledge. If this is achieved, a more engaged workforce will result, and this will
help improve business performance, increase efficiencies, and build better, more robust processes.
Digital transformation is happening and for the pharmaceutical and life-science sector it will not be just a
transformation of technology. It will also require a transformation of policies, processes, and cultures to
drive their organisations to a new level of competitiveness. Emerging technologies and the understanding of
the power, requirement and value of our people’s tacit knowledge will have a key role in driving the industry
forward. Without these working together, opportunities to innovate and continuously improve will be lost.

Recommendation
Fourteen years after ICH Q10 was first released, the industry is now starting to realise that people and
technology working together are critical to the success of pharmaceutical companies. ISPE’s Industry 5.0 has
now a strong refocuses on ‘people’ and this is a welcome development. Co-operation between people and
emerging technologies combines human intelligence and digitalisation. It is important that this connection
is understood better and that learning and development and educational programs are designed to advance
this and take advantage of the tacit knowledge that exists. Further research into this area would be of
significant benefit to the pharmaceutical industry.
It is important to highlight that digitalisation and regulation should go hand-in-hand. Implementation of
these new technologies will require assessment on a case-by-case basis. However, a platform approach could
be adopted. Further research to identify the requirements in the regulatory space should be undertaken –
as digital transformation of the pharmaceutical manufacturing landscape cannot take place without an
understanding of what the key regulation requirement are.
Finally, training effectiveness for pharmaceutical staff who use emerging technologies within GMP facilities
such as mixed reality should also be assessed. Establishing methods to measure “Training Effectiveness”
using this technology should be undertaken.
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